Working… Menu

Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01286649
Recruitment Status : Completed
First Posted : January 31, 2011
Last Update Posted : March 8, 2017
Pharmalog Institut für klinische Forschung GmbH (PHARMALOG Institute for Clinical Research)
PRA Health Sciences
Innovacell Biotechnologie AG
DatInf (Germany)
The Hair and Skin Research and Treatment Center
Information provided by (Responsible Party):
RepliCel Life Sciences, Inc. ( TrichoScience Innovations, Inc. )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2012
Actual Study Completion Date : February 23, 2017